OOIR: Observatory of International Research

Papers

(The H4-Index of ChemMedChem is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes	116
Cyclobutanes in Small‐Molecule Drug Candidates	108
Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections	96
A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**	94
Strategies To Design Selective Histone Deacetylase Inhibitors	63
Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer	60
Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review	57
Benzimidazoles in Drug Discovery: A Patent Review	56
2‐Isoxazolines: A Synthetic and Medicinal Overview	50
Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics	46
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships	45
A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery	45
Coinage Metal N‐Heterocyclic Carbene Complexes: Recent Synthetic Strategies and Medicinal Applications	44
Fluorinated Cycloalkyl Building Blocks for Drug Discovery	43
E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity	43
Gold(I) and Gold(III) N‐Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase	42
Cyclic Dipeptide: A Privileged Molecular Scaffold to Derive Structural Diversity and Functional Utility	42
Do Drug‐likeness Rules Apply to Oral Prodrugs?	42
Functional Nanomaterials in Biomedicine: Current Uses and Potential Applications	39
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19	39
When Virtual Screening Yields Inactive Drugs: Dealing with False Theoretical Friends	38
Malaria Pigment Crystals: The Achilles′ Heel of the Malaria Parasite	37
A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads	37
Excited State and Reactive Oxygen Species against Cancer and Pathogens: A Review on Sonodynamic and Sono‐Photodynamic Therapy	36
Carbon Dots as Drug Delivery Vehicles for Antimicrobial Applications: A Minireview	36

MPI8 is Potent against SARS‐CoV‐2 by Inhibiting Dually and Selectively the SARS‐CoV‐2 Main Protease and the Host Cathepsin L**	36
The Role of Chronic Inflammation in Various Diseases and Anti‐inflammatory Therapies Containing Natural Products	36
A CaO₂@Tannic Acid‐Fe^III Nanoconjugate for Enhanced Chemodynamic Tumor Therapy	35
1,2,4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase	35
Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs	33
Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis	32
Emerging Nitric Oxide and Hydrogen Sulfide Releasing Carriers for Skin Wound Healing Therapy	31